ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: FR-PO551

Abdominal Obesity in Normal Weight versus Overweight and Obese Hemodialysis Patients: Associations with Nutrition, Inflammation, Muscle Strength, and Quality of Life

Session Information

Category: Dialysis

  • 701 Dialysis: Hemodialysis and Frequent Dialysis

Authors

  • Beberashvili, Ilia, Nephrology Division, Zerifin, Israel
  • Azar, Ada, Nutrition Department, Zerifin, Israel
  • Abu hamad, Ramzia, Nephrology Division, Zerifin, Israel
  • Sinuani, Inna, Assuta Ashdod Medical Center , Ashdod, Israel
  • Feldman, Leonid, Nephrology Division, Zerifin, Israel
  • Efrati, Shai, Nephrology Division, Zerifin, Israel
Background

The biological basis of abdominal obesity leading to more severe outcomes in maintenance hemodialysis (MHD) patients with normal body mass index (BMI) is unclear. We compared the phenotype of abdominal obesity in different BMI categories of MHD patients.

Methods


We performed a cross-sectional study of 188 MHD patients (52.7% women; mean age, 69.4±11.5 years) with abdominal obesity in different BMI groups using WHO criteria. Appetite and dietary intake, body composition, handgrip strength, malnutrition-inflammation score (MIS), inflammatory biomarkers, adipokines and health-related quality of life (QoL) questionnaires were studied.

Results

According to multivariable analyses, abdominally obese patients with normal BMIs consumed less protein per day (p=0.04), had lower measurements of surrogates of lean (p<0.001) and fat mass (p<0.001), higher total cholesterol, TNF-α (p<0.05), and adiponectin to leptin ratios (p=0.003) compared to overweight and obese patients with abdominal obesity. Multivariable analyses showed no differences in handgrip strength among the study groups.The abdominally obese study participants with normal weight had significantly lower scores in role-physical (p=0.003) and pain (p=0.04) scales after multivariable adjustments.

Conclusion


Normal weight MHD patients with abdominal obesity exhibit a more proatherogenic profile in terms of inflammatory markers and adipokines expression, lower body composition reserves and lower physical ability compared to abdominal obesity patients with overweight and obesity. This at least partially explains the abdominal obesity paradox in MHD population in which worse clinical outcomes are seen in abdominally obese patients with normal BMIs, as opposed to overweight and obese patients who are also abdominally obese.

Funding

  • NIDDK Support